SignalXSignalX

PBH Prestige Consumer Healthcare Inc.

Q4 2025 10-Q
Filed: Feb 5, 2026Period ending Dec 31, 2025
Health Care
Pharmaceutical PreparationsSEC EDGAR
Prestige Consumer Healthcare Inc. Overview

Prestige Consumer Healthcare Inc. (PBH) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Feb 5, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q4 2025 10-Q

Risk Factors

  • • New risk: Acquisition of Pillar5 Pharma in Dec 2025 triggered increased borrowing of $40M under asset-based revolver to partially fund deal
  • • Most materially updated risk: Supply chain disruptions causing product shortages, especially Eye & Ear Care, negatively impacting sales and operations
+3 more insights

Get deeper insights on Prestige Consumer Healthcare Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.